Research ExplorerJournalsANN ONCOL Publications

ANN ONCOL

1 - 50 out of 108Page size: 50

Publications

  1. 2024

  2. Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey

    Comoli, P., Pentheroudakis, G., Ruggeri, A., Koehl, U., Lordick, F., Mooyaart, J. E., Hoogenboom, J. D., Urbano-Ispizua, A., Peters, S., Kuball, J., Kröger, N., Sureda, A., Chabannon, C., Haanen, J., Pedrazzoli, P. & EBMT Cellular Therapy & Immunobiology Working Party, 04.2024, In: ANN ONCOL. 35, 4, p. 404-406 3 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  3. 2023

  4. Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2- early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2- trial

    Gluz, O., Kuemmel, S., Nitz, U., Braun, M., Lüdtke-Heckenkamp, K., von Schumann, R., Darsow, M., Forstbauer, H., Potenberg, J., Uleer, C., Grischke, E. M., Aktas, B., Schumacher, C., Zu Eulenburg, C., Kates, R., Jóźwiak, K., Graeser, M., Wuerstlein, R., Baehner, R., Christgen, M., Kreipe, H. H. & Harbeck, N., 06.2023, In: ANN ONCOL. 34, 6, p. 531-542 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Falanga, A., Ay, C., Di Nisio, M., Gerotziafas, G., Jara-Palomares, L., Langer, F., Lecumberri, R., Mandala, M., Maraveyas, A., Pabinger, I., Sinn, M., Syrigos, K., Young, A., Jordan, K. & ESMO Guidelines Committee, 05.2023, In: ANN ONCOL. 34, 5, p. 452-467 16 p.

    Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review

  6. 2022

  7. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmaña, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S-A., Jager, A., Jóhannsson, Ó. Þ., Lakhani, S. R., Janni, W., Linderholm, B., Liu, T-W., Loman, N., Korde, L., Loibl, S., Lucas, P. C., Marmé, F., Martinez de Dueñas, E., McConnell, R., Phillips, K-A., Piccart, M., Rossi, G., Schmutzler, R., Senkus, E., Shao, Z., Sharma, P., Singer, C. F., Španić, T., Stickeler, E., Toi, M., Traina, T. A., Viale, G., Zoppoli, G., Park, Y. H., Yerushalmi, R., Yang, H., Pang, D., Jung, K. H., Mailliez, A., Fan, Z., Tennevet, I., Zhang, J., Nagy, T., Sonke, G. S., Sun, Q., Parton, M., Colleoni, M. A., Schmidt, M., Brufsky, A. M., Razaq, W., Kaufman, B., Cameron, D., Campbell, C., Tutt, A. N. J. & OlympiA Clinical Trial Steering Committee and Investigators, 12.2022, In: ANN ONCOL. 33, 12, p. 1250-1268 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    Pascual, J., Attard, G., Bidard, F-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., Normanno, N., Pantel, K., Pentheroudakis, G., Popat, S., Reis-Filho, J. S., Tie, J., Seoane, J., Tarazona, N., Yoshino, T. & Turner, N. C., 08.2022, In: ANN ONCOL. 33, 8, p. 750-768 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

    Janning, M., Süptitz, J., Albers-Leischner, C., Delpy, P., Tufman, A., Velthaus-Rusik, J-L., Reck, M., Jung, A., Kauffmann-Guerrero, D., Bonzheim, I., Brändlein, S., Hummel, H-D., Wiesweg, M., Schildhaus, H-U., Stratmann, J. A., Sebastian, M., Alt, J., Buth, J., Esposito, I., Berger, J., Tögel, L., Saalfeld, F. C., Wermke, M., Merkelbach-Bruse, S., Hillmer, A. M., Klauschen, F., Bokemeyer, C., Buettner, R., Wolf, J. & Loges, S., 06.2022, In: ANN ONCOL. 33, 6, p. 602-615 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

    Oldenburg, J., Berney, D. M., Bokemeyer, C., Climent, M. A., Daugaard, G., Gietema, J. A., De Giorgi, U., Haugnes, H. S., Huddart, R. A., Leão, R., Sohaib, A., Gillessen, S., Powles, T. & ESMO Guidelines Committee, 04.2022, In: ANN ONCOL. 33, 4, p. 362-375 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Vergote, I., González-Martín, A., Ray-Coquard, I., Harter, P., Colombo, N., Pujol, P., Lorusso, D., Mirza, M. R., Brasiuniene, B., Madry, R., Brenton, J. D., Ausems, M. G. E. M., Büttner, R., Lambrechts, D. & European experts’ consensus group, 03.2022, In: ANN ONCOL. 33, 3, p. 276-287 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  12. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

    Hayden, P. J., Roddie, C., Bader, P., Basak, G. W., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M. J., Köhl, U., Kuball, J., Mielke, S., Mohty, M., Murray, J., Nagler, A., Rees, J., Rioufol, C., Saccardi, R., Snowden, J. A., Styczynski, J., Subklewe, M., Thieblemont, C., Topp, M., Ispizua, Á. U., Chen, D., Vrhovac, R., Gribben, J. G., Kröger, N., Einsele, H. & Yakoub-Agha, I., 03.2022, In: ANN ONCOL. 33, 3, p. 259-275 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis

    Curigliano, G., Mueller, V., Borges, V., Hamilton, E., Hurvitz, S., Loi, S., Murthy, R., Okines, A., Paplomata, E., Cameron, D., Carey, L. A., Gelmon, K., Hortobagyi, G. N., Krop, I., Loibl, S., Pegram, M., Slamon, D., Ramos, J., Feng, W. & Winer, E., 03.2022, In: ANN ONCOL. 33, 3, p. 321-329 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2021

  15. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Miles, D., Ciruelos, E., Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Campone, M., Bondarenko, I., Nowecki, Z., Errihani, H., Paluch-Shimon, S., Wardley, A., Merot, J-L., Trask, P., du Toit, Y., Pena-Murillo, C., Revelant, V., Klingbiel, D., Bachelot, T. & PERUSE investigators, 10.2021, In: ANN ONCOL. 32, 10, p. 1245-1255 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆

    Denkert, C., Untch, M., Benz, S., Schneeweiss, A., Weber, K. E., Schmatloch, S., Jackisch, C., Sinn, H. P., Golovato, J., Karn, T., Marmé, F., Link, T., Budczies, J., Nekljudova, V., Schmitt, W. D., Stickeler, E., Müller, V., Jank, P., Parulkar, R., Heinmöller, E., Sanborn, J. Z., Schem, C., Sinn, B. V., Soon-Shiong, P., van Mackelenbergh, M., Fasching, P. A., Rabizadeh, S. & Loibl, S., 04.2021, In: ANN ONCOL. 32, 4, p. 500-511 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2020

  18. Prognostic gene expression signature for high-grade serous ovarian cancer

    Millstein, J., Budden, T., Goode, E. L., Anglesio, M. S., Talhouk, A., Intermaggio, M. P., Leong, H. S., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R. C., Wang, C., Chiu, D. S., Kommoss, S., Leung, S. C. Y., Senz, J., Lum, A., Chow, V., Sudderuddin, H., Mackenzie, R., George, J., Fereday, S., Hendley, J., Traficante, N., Steed, H., Koziak, J. M., Köbel, M., McNeish, I. A., Goranova, T., Ennis, D., Macintyre, G., Silva De Silva, D., Ramón Y Cajal, T., García-Donas, J., Hernando Polo, S., Rodriguez, G. C., Cushing-Haugen, K. L., Harris, H. R., Greene, C. S., Zelaya, R. A., Behrens, S., Fortner, R. T., Sinn, P., Herpel, E., Lester, J., Lubiński, J., Oszurek, O., Tołoczko, A., Cybulski, C., Menkiszak, J., Pearce, C. L., Pike, M. C., Tseng, C., Alsop, J., Rhenius, V., Song, H., Jimenez-Linan, M., Piskorz, A. M., Gentry-Maharaj, A., Karpinskyj, C., Widschwendter, M., Singh, N., Kennedy, C. J., Sharma, R., Harnett, P. R., Gao, B., Johnatty, S. E., Sayer, R., Boros, J., Winham, S. J., Keeney, G. L., Kaufmann, S. H., Larson, M. C., Luk, H., Hernandez, B. Y., Thompson, P. J., Wilkens, L. R., Carney, M. E., Trabert, B., Lissowska, J., Brinton, L., Sherman, M. E., Bodelon, C., Hinsley, S., Lewsley, L. A., Glasspool, R., Banerjee, S. N., Stronach, E. A., Haluska, P., Ray-Coquard, I., Mahner, S., Winterhoff, B., Slamon, D., Levine, D. A., Kelemen, L. E., Benitez, J., Chang-Claude, J., Gronwald, J., Wu, A. H., Menon, U., Goodman, M. T., Schildkraut, J. M., Wentzensen, N., Brown, R., Berchuck, A., Chenevix-Trench, G., deFazio, A., Gayther, S. A., García, M. J., Henderson, M. J., Rossing, M. A., Beeghly-Fadiel, A., Fasching, P. A., Orsulic, S., Karlan, B. Y., Konecny, G. E., Huntsman, D. G., Bowtell, D. D., Brenton, J. D., Doherty, J. A., Pharoah, P. D. P., Ramus, S. J. & AOCS study group, 09.2020, In: ANN ONCOL. 31, 9, p. 1240-1250 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

    Karn, T., Denkert, C., Weber, K. E., Holtrich, U., Hanusch, C., Sinn, B. V., Higgs, B. W., Jank, P., Sinn, H. P., Huober, J., Becker, C., Blohmer, J-U., Marmé, F., Schmitt, W. D., Wu, S., van Mackelenbergh, M., Müller, V., Schem, C., Stickeler, E., Fasching, P. A., Jackisch, C., Untch, M., Schneeweiss, A. & Loibl, S., 09.2020, In: ANN ONCOL. 31, 9, p. 1216-1222 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 2019

  21. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†

    Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H. M., De Reijke, T. M., De Santis, M., Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M. J., Shariat, S. F., Van Der Kwast, T., Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P. C., Bochner, B. H., Bolla, M., Boormans, J. L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., Culine, S., De Bari, B., DeBlok, W., De Visschere, P. J. L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J. L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J. J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D. E., Hayne, D., Henry, A. M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B. A., Jones, R., Kamat, A. M., Khoo, V., Kiltie, A. E., Krege, S., Ladoire, S., Lara, P. C., Leliveld, A., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Carmen Mir, M., Moschini, M., Mostafid, H., N'Dow, J., Necchi, A., Neuzillet, Y., Oddens, J. R., Oldenburg, J., Osanto, S., Oyen, W. J. G., Pacheco-Figueiredo, L., Pappot, H., Patel, M. I., Pieters, B. R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R. J., Smits, A., Stenzl, A., Thalmann, G. N., Tombal, B., Turkbey, B., Vahr Lauridsen, S., Valdagni, R., Van Der Heijden, A. G., Van Poppel, H., Vartolomei, M. D., Veskimäe, E., Vilaseca, A., Vives Rivera, F. A., Wiegel, T., Wiklund, P., Williams, A., Zigeuner, R. & Witjes, J. A., 01.11.2019, In: ANN ONCOL. 30, 11, p. 1697-1727 31 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

    PERUSE investigators, 01.05.2019, In: ANN ONCOL. 30, 5, p. 766-773 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Recent advances in Circulating Nucleic Acids in oncology

    Otandault, A., Anker, P., Al Amir Dache, Z., Guillaumon, V., Meddeb, R., Pastor, B., Pisareva, E., Sanchez, C., Tanos, R., Tousch, G., Schwarzenbach, H. & Thierry, A. R., 01.03.2019, In: ANN ONCOL. 30, 3, p. 374-384 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  24. 2018

  25. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., Österborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., Jordan, K., Herrstedt, J. & ESMO Guidelines Committee, 01.10.2018, In: ANN ONCOL. 29, Suppl 4, p. iv96-iv110

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. ESMO Consensus Conference on testicular germ cell cancer: past, present, and future considerations: diagnosis, treatment and follow-up

    Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., Clarke, N., Cohn-Cedermark, G., Daugaard, G., Dieckmann, K-P., Fizazi, K., Fosså, S., Germa-Lluch, J. R., Giannatempo, P., Gietema, J. A., Gillessen, S., Haugnes, H. S., Heidenreich, A., Hemminki, K., Huddart, R., Jewett, M. A. S., Joly, F., Lauritsen, J., Lorch, A., Necchi, A., Nicolai, N., Oing, C., Oldenburg, J., Ondruš, D., Papachristofilou, A., Powles, T., Sohaib, A., Ståhl, O., Tandstad, T., Toner, G. & Horwich, A., 01.08.2018, In: ANN ONCOL. 29, 8, p. 1658-1686 29 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Trastuzumab versus observation for HER2 non amplified early breast cancer with Circulating Tumor Cells (EORTC 90091-10093, BIG 1-12, Treat CTC): A randomized phase 2 trial

    Ignatiadis, M., Litière, S., Rothe, F., Riethdorf, S., Proudhon, C., Fehm, T., Aalders, K., Forstbauer, H., Fasching, P., Brain, E., Vuylsteke, P., Guardiola, E., Lorenz, R., Pantel, K., Tryfonidis, K., Janni, W., Piccart, M., Sotiriou, C., Rack, B. & Pierga, J-Y., 01.08.2018, In: ANN ONCOL. 29, 8, p. 1777-1783 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Beyond Second-Line Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

    Arnold, D., Prager, G. W., Quintela, A., Stein, A., Moreno, S., Mounedji, N. & Taieb, J., 01.04.2018, In: ANN ONCOL. 29, 4, p. 835-856 22 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Education › peer-review

  29. RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

    Carmeliet, P., Li, X., Treps, L., Conradi, L-C. & Loges, S., 01.03.2018, In: ANN ONCOL. 29, 3, p. 527-529 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  30. Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

    Möbus, V., Jackisch, C., Lück, H. J., du Bois, A., Thomssen, C., Kuhn, W., Nitz, U., Schneeweiss, A., Huober, J., Harbeck, N., von Minckwitz, G., Runnebaum, I. B., Hinke, A., Konecny, G. E., Untch, M., Kurbacher, C. & AGO Breast Study Group (AGO-B), 01.01.2018, In: ANN ONCOL. 29, 1, p. 178-185 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2017

  32. SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

    Sinn, M., Sinn, B. V., Striefler, J. K., Lindner, J. L., Stieler, J. M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H. & Denkert, C., 01.11.2017, In: ANN ONCOL. 28, 11, p. 2900

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

    Möbus, V., von Minckwitz, G., Jackisch, C., Lück, H-J., Schneeweiss, A., Tesch, H., Elling, D., Harbeck, N., Conrad, B., Fehm, T., Huober, J., Müller, V., Bauerfeind, I., du Bois, A., Loibl, S., Nekljudova, V., Untch, M., Thomssen, C. & German Breast Group (GBG), the AGO Breast Study Group (AGO-B) and NOGGO Study Groups, 01.08.2017, In: ANN ONCOL. 28, 8, p. 1803-1810 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. LBA-007FOLFOX/Bevacizumab +/- Irinotecan in advanced colorectal cancer (AIO) "CHARTA": Final results and multivariate prognostic factor analysis

    Schmoll, H-J., Garlipp, B., Junghanß, C., Leithäuser, M., Vogel, A., Schaefers, M., Kaiser, U., Hoeffkes, H-G., Florschütz, A., Rüssel, J., Kanzler, S., Edelmann, T., Forstbauer, H., Göhler, T., Hannig, C., Hildebrandt, B., Steighardt, J., Cygon, F., Meinert, F. & Stein, A., 01.06.2017, In: ANN ONCOL. 28, suppl_3

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  35. Impact of Primary Metastatic Bone Disease in Germ Cell Tumors: Results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

    Oing, C., Oechsle, K., Necchi, A., Loriot, Y., De Giorgi, U., Fléchon, A., Daugaard, G., Fedyanin, M., Faré, E. & Bokemeyer, C., 01.05.2017, In: ANN ONCOL. 28, 3, p. 576-582

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation

    Schrader, J., Henes, F. O., Perez, D., Burdak-Rothkamm, S., Stein, A., Izbicki, J. R. & Lohse, A. W., 01.04.2017, In: ANN ONCOL. 28, 4, p. 904-905

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  37. 2016

  38. Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial

    Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C. A., Killing, B., Depenbusch, R., Steffens, C-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H-J., Hinke, A., Al-Batran, S-E. & Arnold, D., 12.2016, In: ANN ONCOL. 27, 12, p. 2203-2210 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)

    Aapro, M., Ludwig, H., Bokemeyer, C., Gascón, P., Boccadoro, M., Denhaerynck, K., Krendyukov, A., Gorray, M., MacDonald, K. & Abraham, I., 11.2016, In: ANN ONCOL. 27, 11, p. 2039-2045 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study

    Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U-S. & Rief, W., 10.2016, In: ANN ONCOL. 27, 10, p. 1909-15

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial

    Eigentler, T. K., Gutzmer, R., Hauschild, A., Heinzerling, L., Schadendorf, D., Nashan, D., Hölzle, E., Kiecker, F., Becker, J., Sunderkötter, C., Moll, I., Richtig, E., Pönitzsch, I., Pehamberger, H., Kaufmann, R., Pföhler, C., Vogt, T., Berking, C., Praxmarer, M., Garbe, C. & Dermatologic Cooperative Oncology Group (DeCOG), 08.2016, In: ANN ONCOL. 27, 8, p. 1625-32 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Schmidt-Hieber, M., Silling, G., Schalk, E., Heinz, W., Panse, J., Penack, O., Christopeit, M., Buchheidt, D., Meyding-Lamadé, U., Hähnel, S., Wolf, H. H., Ruhnke, M., Schwartz, S. & Maschmeyer, G., 07.2016, In: ANN ONCOL. 27, 7, p. 1207-25 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

    Mackey, J. R., Pieńkowski, T., Crown, J., Sadeghi, S., Martin, M., Chan, A., Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M. F., Sauter, G., Lindsay, M., Houé, V., Buyse, M., Drevot, P., Hitier, S., Bensfia, S. & Eiermann, W., 06.2016, In: ANN ONCOL. 27, 6, p. 1041-7 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2015

  45. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Vannucchi, A. M., Barbui, T., Cervantes, F., Harrison, C., Kiladjian, J-J., Kröger, N., Thiele, J., Buske, C. & ESMO Guidelines Committee, 09.2015, In: ANN ONCOL. 26 Suppl 5, p. v85-99

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

    Vansteenkiste, J., Barlesi, F., Waller, C. F., Bennouna, J., Gridelli, C., Goekkurt, E., Verhoeven, D., Szczesna, A., Feurer, M., Milanowski, J., Germonpre, P., Lena, H., Atanackovic, D., Krzakowski, M., Hicking, C., Straub, J., Picard, M., Schuette, W. & O'Byrne, K., 08.2015, In: ANN ONCOL. 26, 8, p. 1734-40 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma

    Gakis, G., Morgan, T. M., Daneshmand, S., Keegan, K. A., Todenhöfer, T., Mischinger, J., Schubert, T., Zaid, H. B., Hrbacek, J., Ali-El-Dein, B., Clayman, R. H., Galland, S., Olugbade, K., Rink, M., Fritsche, H-M., Burger, M., Chang, S. S., Babjuk, M., Thalmann, G. N., Stenzl, A. & Efstathiou, J. A., 08.2015, In: ANN ONCOL. 26, 8, p. 1754-9 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

    Oldenburg, J., Aparicio, J., Beyer, J., Cohn-Cedermark, G., Cullen, M., Gilligan, T., De Giorgi, U., De Santis, M., de Wit, R., Fosså, S. D., Germà-Lluch, J. R., Gillessen, S., Haugnes, H. S., Honecker, F., Horwich, A., Lorch, A., Ondruš, D., Rosti, G., Stephenson, A. J., Tandstad, T. & SWENOTECA (Swedish Norwegian Testicular Cancer group), the Italian Germ Cell Cancer Group (IGG), Spanish Germ Cell Cancer Group (SGCCG), 01.05.2015, In: ANN ONCOL. 26, 5, p. 833-838 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., Calaminus, G., Capra, M., Deffenbaugh, C., Dhooge, C., Eriksson, M., Flanagan, A. M., Gelderblom, H., Goorin, A., Gorlick, R., Gosheger, G., Grimer, R. J., Hall, K. S., Helmke, K., Hogendoorn, P. C. W., Jundt, G., Kager, L., Kuehne, T., Lau, C. C., Letson, G. D., Meyer, J., Meyers, P. A., Morris, C., Mottl, H., Nadel, H., Nagarajan, R., Randall, R. L., Schomberg, P., Schwarz, R., Teot, L. A., Sydes, M. R., Bernstein, M. & EURAMOS collaborators, 02.2015, In: ANN ONCOL. 26, 2, p. 407-14 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial

    Élez, E., Kocáková, I., Höhler, T., Martens, U. M., Bokemeyer, C., Van Cutsem, E., Melichar, B., Smakal, M., Csőszi, T., Topuzov, E., Orlova, R., Tjulandin, S., Rivera, F., Straub, J., Bruns, R., Quaratino, S. & Tabernero, J., 01.01.2015, In: ANN ONCOL. 26, 1, p. 132-140 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

    Lindner, J. L., Loibl, S., Denkert, C., Ataseven, B., Fasching, P. A., Pfitzner, B. M., Gerber, B., Gade, S., Darb-Esfahani, S., Sinn, B. V., Huober, J., Engels, K., Tesch, H., Karn, T., Pommerenke, F., Liedtke, C., Untch, M., Müller, V., Rack, B., Schem, C. & von Minckwitz, G., 01.01.2015, In: ANN ONCOL. 26, 1, p. 95-100 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. 2014

  53. Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†

    von Minckwitz, G., Loibl, S., Untch, M., Eidtmann, H., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Schrader, I., Kittel, K., Hanusch, C., Huober, J., Solbach, C., Jackisch, C., Kunz, G., Blohmer, J. U., Hauschild, M., Fehm, T., Nekljudova, V., Gerber, B. & GBG/AGO-B study groups, 01.12.2014, In: ANN ONCOL. 25, 12, p. 2363-2372 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

    Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L. & PrefHer Study Group, 01.10.2014, In: ANN ONCOL. 25, 10, p. 1979-1987 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study

    Trillsch, F., Mahner, S., Woelber, L., Vettorazzi, E., Reuss, A., Ewald-Riegler, N., de Gregorio, N., Fotopoulou, C., Schmalfeldt, B., Burges, A., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H. G., Hellriegel, M., Wimberger, P., Baumann, K., Keyver-Paik, M. D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schroeder, W., Muenstedt, K., Richter, B., Kommoss, F., Hauptmann, S. & du Bois, A., 01.07.2014, In: ANN ONCOL. 25, 7, p. 1320-1327

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology

    Hentrich, M., Schalk, E., Schmidt-Hieber, M., Chaberny, I., Mousset, S., Buchheidt, D., Ruhnke, M., Penack, O., Salwender, H., Wolf, H-H., Christopeit, M., Neumann, S., Maschmeyer, G., Karthaus, M. & Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology, 01.05.2014, In: ANN ONCOL. 25, 5, p. 936-47 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study

    Gandaglia, G., Karakiewicz, P. I., Briganti, A., Trinh, Q. D., Schiffmann, J., Tian, Z., Kim, S. P., Nguyen, P. L., Graefen, M., Montorsi, F., Sun, M. & Abdollah, F., 01.05.2014, In: ANN ONCOL. 25, 5, p. 979-86 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

    Vermorken, J. B., Peyrade, F., Krauss, J., Mesía, R., Remenar, E., Gauler, T. C., Keilholz, U., Delord, J. P., Schafhausen, P., Erfán, J., Brümmendorf, T. H., Iglesias, L., Bethe, U., Hicking, C. & Clement, P. M., 01.03.2014, In: ANN ONCOL. 25, 3, p. 682-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. Phase II Study Evaluating Imatinib to Induce Progression Arrest in Recist Progressive Desmoid Tumors not Amenable to Surgical Resection with R0 Intent or Accompanied by Unacceptable Function Loss-A Study of the German Interdisciplinary Sarcoma Group (GISG)

    Kasper, B., Grünwald, V., Reichardt, P., Bauer, S., Rauch, G., Sommer, M. & Hohenberger, P., 2014, In: ANN ONCOL. 25, suppl 4, p. iv494

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  60. 2013

  61. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy

    Kreth, F-W., Thon, N., Simon, M., Westphal, M., Schackert, G., Nikkhah, G., Hentschel, B., Reifenberger, G., Pietsch, T., Weller, M., Tonn, J-C. & German Glioma Network, 01.12.2013, In: ANN ONCOL. 24, 12, p. 3117-23 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  62. Surgical intervention in relapsed ovarian cancer is beneficial: pro

    Harter, P., Heitz, F., Mahner, S., Hilpert, F. & du Bois, A., 01.12.2013, In: ANN ONCOL. 24 Suppl 10, p. x33-34

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next